Home Emendo Biotherapeutics

Emendo Biotherapeutics

Emendo Biotherapeutics Raises $61 Million

The financing provides a strong foundation from which we can accelerate our proprietary OMNI gene-editing platform towards a broad clinical pipeline for addressing devastating untreatable diseases.